Progressive muscular dystrophies.

作者: Jamel Chelly , Isabelle Desguerre

DOI: 10.1016/B978-0-444-59565-2.00006-X

关键词: Genetic heterogeneityGenetic counselingMuscular dystrophyMuscle weaknessWeaknessMyologyEndomysiumPerimysiumBiologyPathology

摘要: Infancy- or childhood-onset muscular dystrophies may be associated with profound loss of muscle function, affecting ambulation, posture, cardiac and respiratory functions, while those late onset mild slight weakness fatigability induced by effort. In addition to the distribution weakness, symptoms, course disease, diagnosis dystrophy is usually ascertained histological findings. There connective tissue proliferation in perimysium endomysium, variation fiber size, cytoarchitectural alterations myofibers such as internal nuclei, myofibrillar whorls, splitting lobulation, but, most all, degeneration regeneration myofibers. Causes characterized wasting are heterogeneous include dysfunction diverse genetic pathways genes encoding proteins plasma membrane, extracellular matrix, sarcomere, nuclear membrane components. Duchenne Becker prototypes illustrating advances field myology. Limb-girdle (LGMDs) clinically genetically heterogeneous, some autosomal dominant (LGMD1) others recessive (LGMD2) inheritance. Neither clinical grounds nor biopsy patterns specific enough distinguish them, but two common denominators are: (1) predominating pelvic shoulder girdle muscles, occasional involvement myocardium; (2) necrosis While identification causes molecular increasingly improved, especially advent new generation sequencing technologies, optimized care, information for family, prevention, including counseling prenatal diagnosis, require multidisciplinary follow-up genetic, pediatric, psychological involvement.

参考文章(76)
Craig M. McDonald, Richard T. Abresch, Gregory T. Carter, William M. Fowler, E Ralph Johnson, David D. Kilmer, Barbara J. Sigford, Duchenne Muscular Dystrophy American Journal of Physical Medicine & Rehabilitation. ,vol. 74, pp. S70- S92 ,(1995) , 10.1097/00002060-199509001-00003
Alexander Zimprich, Monika Grabowski, Friedrich Asmus, Markus Naumann, Daniela Berg, Markus Bertram, Karl Scheidtmann, Peter Kern, Juliane Winkelmann, Bertram Müller-Myhsok, Leonhard Riedel, Matthias Bauer, Tanja Müller, Mirna Castro, Thomas Meitinger, Tim M. Strom, Thomas Gasser, Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nature Genetics. ,vol. 29, pp. 66- 69 ,(2001) , 10.1038/NG709
Vandana Shashi, Pamela Clark, Alan D. Rogol, William G. Wilson, Spectrum of small mutations in the dystrophin coding region American Journal of Human Genetics. ,vol. 57, pp. 22- 33 ,(1995) , 10.1002/AJMG.1320570107
Xin Huang, Florence Poy, Rongguang Zhang, Andrzej Joachimiak, Marius Sudol, Michael J. Eck, Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan. Nature Structural & Molecular Biology. ,vol. 7, pp. 634- 638 ,(2000) , 10.1038/77923
AY Manzur, T Kuntzer, M Pike, A Swan, Glucocorticoid corticosteroids for Duchenne muscular dystrophy Cochrane Database of Systematic Reviews. ,(2004) , 10.1002/14651858.CD003725.PUB2
Leland E. Lim, Kevin P. Campbell, The sarcoglycan complex in limb-girdle muscular dystrophy. Current Opinion in Neurology. ,vol. 11, pp. 443- 452 ,(1998) , 10.1097/00019052-199810000-00006
Eugenio Mercuri, Kate Bushby, Enzo Ricci, Daniel Birchall, Marika Pane, Maria Kinali, Joanna Allsop, Vincenzo Nigro, Amets Sáenz, Annachiara Nascimbeni, Luigi Fulizio, Corrado Angelini, Francesco Muntoni, Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscular Disorders. ,vol. 15, pp. 164- 171 ,(2005) , 10.1016/J.NMD.2004.10.008
Salvatore Grosso, Rosa Mostardini, Rosanna Maria Di Bartolo, Paolo Balestri, Alberto Verrotti, Epilepsy, speech delay, and mental retardation in facioscapulohumeral muscular dystrophy European Journal of Paediatric Neurology. ,vol. 15, pp. 456- 460 ,(2011) , 10.1016/J.EJPN.2011.04.003